Complete Filing Data
Orchestra BioMed Holdings, Inc. reported Net Income Loss of -$52.70 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Orchestra BioMed Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$52.7M | -$61.0M | -$49.1M | -$33.6M | -$378.8K |
| Operating Income Loss | -$51.8M | -$64.3M | -$51.5M | -$32.7M | -$394.8K |
| General And Administrative Expense | $3.0M | $274.8K | |||
| Selling General And Administrative Expense | $26.9M | $23.9M | $20.3M | $14.0M | |
| Revenues | $33.5M | $2.6M | $2.8M | $3.5M | |
| Research And Development Expense | $58.2M | $42.8M | $33.8M | $21.9M | |
| Cost Of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | |
| Comprehensive Income Net Of Tax | -$52.7M | -$61.0M | -$49.1M | -$33.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$20.8M | -$19.4M | -$18.8M | -$15.4M | -$16.0M | -$13.5M | -$13.3M | -$12.0M | -$10.9M | -$10.3M | -$7.8M | -$5.7M | -$90.4K | -$92.3K | -$108.0K | -$66.2K | -$15.2K |
| Operating Income Loss | -$20.3M | -$19.3M | -$18.9M | -$16.3M | -$16.9M | -$14.4M | -$14.5M | -$13.0M | -$11.5M | -$10.1M | -$7.6M | -$5.1M | -$94.4K | -$96.3K | -$111.9K | -$68.6K | -$15.2K |
| General And Administrative Expense | $783.4K | $908.2K | $422.0K | $64.4K | $66.3K | $81.9K | $68.6K | $15.2K | |||||||||
| Selling General And Administrative Expense | $7.1M | $6.3M | $6.3M | $5.7M | $6.5M | $5.9M | $6.3M | $5.3M | $4.4M | $5.3M | $2.9M | $2.5M | |||||
| Revenues | $861.0K | $836.0K | $868.0K | $987.0K | $778.0K | $620.0K | $419.0K | $915.0K | $1.2M | $1.2M | $401.0K | $866.0K | |||||
| Research And Development Expense | $14.0M | $13.9M | $13.5M | $11.6M | $11.1M | $9.1M | $8.6M | $8.5M | $8.3M | $5.9M | $5.0M | $3.5M | |||||
| Cost Of Revenue | $49.0K | $46.0K | $44.0K | $68.0K | $44.0K | $34.0K | $41.0K | $54.0K | $44.0K | $56.0K | $60.0K | $42.0K | |||||
| Comprehensive Income Net Of Tax | -$20.8M | -$19.4M | -$18.8M | -$15.3M | -$16.0M | -$13.5M | -$13.3M | -$12.1M | -$11.0M | -$10.3M | -$7.8M | -$5.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $53.6M | $33.0M | $68.0M | $52.5M | -$19.8M | -$3.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $34.7M | $22.3M | $30.6M | $19.8M | $9.9M | $2.0M |
| Liabilities Current | $16.7M | $16.2M | $11.2M | $18.6M | $165.5K | $119.0K |
| Liabilities And Stockholders Equity | $114.9M | $76.2M | $95.2M | $95.6M | $161.8M | $162.2M |
| Liabilities | $51.5M | $43.2M | $27.2M | $43.0M | $5.8M | $5.7M |
| Common Stock Value | $6.0K | $4.0K | $4.0K | $2.0K | $445.00 | $445.00 |
| Assets Current | $107.9M | $69.2M | $89.1M | $84.7M | $1.8M | $2.1M |
| Assets | $114.9M | $76.2M | $95.2M | $95.6M | $161.8M | $162.2M |
| Accrued Liabilities Current | $9.9M | $6.1M | $5.1M | $5.4M | $14.2K | $75.1K |
| Accounts Payable Current | $6.1M | $5.1M | $2.9M | $4.0M | $1.4K | $13.8K |
| Retained Earnings Accumulated Deficit | -$362.6M | -$309.9M | -$248.9M | -$199.7M | -$3.9M | -$3.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $12.4M | -$8.3M | $10.8M | $9.8M | -$272.4K | |
| Cash And Cash Equivalents At Carrying Value | $34.7M | $22.3M | $30.6M | $19.8M | $1.8M | |
| Marketable Securities Unrealized Gain Loss | $8.0K | $62.0K | -$2.0K | -$8.0K | ||
| Net Gain From Investments Held In Trust Account | $16.0K | |||||
| Unrealized Gain Loss On Investments | $345.1K | $16.0K | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $67.7M | $160.0M | $160.0M | |||
| Deferred Underwriting Commissions In Connection With The Initial Public Offering | $5.6M | $5.6M | $5.6M | |||
| Gain Loss On Investments | -$68.0K | -$18.0K | $1.0M | |||
| Assets Held In Trust Noncurrent | $67.8M | $160.0M | $160.0M | |||
| Property Plant And Equipment Net | $1.7M | $1.4M | $1.3M | $1.5M | ||
| Prepaid Expense And Other Assets Current | $994.0K | $2.1M | $1.3M | $533.0K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $607.0K | $654.0K | $632.0K | $571.0K | ||
| Inventory Net | $310.0K | $173.0K | $146.0K | $276.0K | ||
| Deposits And Other Assets | $1.2M | $1.0M | $769.0K | $4.7M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $60.0K | $52.0K | -$10.0K | -$8.0K | ||
| Accounts Receivable Net Current | $95.0K | $92.0K | $99.0K | $96.0K | ||
| Operating Lease Right Of Use Asset | $1.5M | $2.1M | $1.6M | $2.2M | ||
| Operating Lease Liability Noncurrent | $936.0K | $1.7M | $1.0M | $1.7M | ||
| Operating Lease Liability Current | $751.0K | $550.0K | $649.0K | $697.0K | ||
| Marketable Securities Current | $71.8M | $44.6M | $57.0M | $63.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $43.7M | $295.0K | $16.9M | $46.2M | $44.1M | $57.2M | $79.7M | $89.4M | $99.8M | $52.5M | -$6.1M | -$5.3M | $78.0K | -$19.8M | -$3.9M | -$3.8M | -$3.7M | -$3.5M | $13.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $42.0M | $18.7M | $18.3M | $25.6M | $23.7M | $23.3M | $19.1M | $16.4M | $18.7M | $97.0M | $107.0M | $29.3M | $1.9M | $2.0M | ||||||
| Liabilities Current | $20.7M | $17.1M | $15.5M | $16.2M | $14.5M | $10.4M | $21.5M | $11.9M | $12.1M | $1.4M | $1.1M | $306.5K | $136.8K | $194.9K | $174.5K | $71.4K | ||||
| Liabilities And Stockholders Equity | $104.8M | $42.8M | $59.1M | $75.3M | $72.4M | $82.6M | $116.4M | $125.9M | $136.3M | $68.6M | $161.6M | $161.5M | $161.9M | $162.0M | $162.1M | $162.2M | ||||
| Liabilities | $61.1M | $42.5M | $42.2M | $29.1M | $28.3M | $25.4M | $36.7M | $36.4M | $36.5M | $7.0M | $6.7M | $5.9M | $5.7M | $5.8M | $5.8M | $5.7M | ||||
| Common Stock Value | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $445.00 | $445.00 | $445.00 | $445.00 | $533.00 | $532.00 | $530.00 | ||||
| Assets Current | $97.8M | $35.9M | $51.9M | $68.6M | $66.5M | $76.4M | $110.2M | $119.6M | $129.9M | $872.6K | $1.3M | $1.5M | $1.9M | $2.0M | $2.1M | $2.2M | ||||
| Assets | $104.8M | $42.8M | $59.1M | $75.3M | $72.4M | $82.6M | $116.4M | $125.9M | $136.3M | $68.6M | $161.6M | $161.5M | $161.9M | $162.0M | $162.1M | $162.2M | ||||
| Accrued Liabilities Current | $6.8M | $6.7M | $5.4M | $7.0M | $4.2M | $3.5M | $4.3M | $3.8M | $3.3M | $1.2M | $927.0K | $202.9K | $15.2K | $85.6K | $79.9K | $70.0K | ||||
| Accounts Payable Current | $8.5M | $5.3M | $5.6M | $4.7M | $6.3M | $3.4M | $3.2M | $3.0M | $2.8M | $281.6K | $170.7K | $103.6K | $1.7K | $19.3K | $34.6K | $1.4K | ||||
| Retained Earnings Accumulated Deficit | -$368.8M | -$348.0M | -$328.6M | -$293.7M | -$278.3M | -$262.3M | -$236.0M | -$222.7M | -$210.7M | -$6.1M | -$5.3M | -$4.4M | -$3.9M | -$373.9K | -$281.5K | -$81.4K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.9M | -$7.2M | -$1.1M | $19.4M | -$76.4K | $2.0M | $193.7K | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $42.0M | $18.7M | $18.3M | $25.6M | $23.7M | $23.3M | $19.1M | $16.4M | $18.7M | $735.2K | $1.3M | $1.4M | $1.8M | $1.9M | $2.0M | $2.0M | $2.0M | $193.7K | ||
| Marketable Securities Unrealized Gain Loss | $29.0K | -$21.0K | -$15.0K | $121.0K | -$15.0K | $2.0K | $19.0K | -$61.0K | -$27.0K | |||||||||||
| Net Gain From Investments Held In Trust Account | $127.6K | $203.3K | $14.3K | $4.0K | $4.0K | $3.9K | $2.4K | |||||||||||||
| Unrealized Gain Loss On Investments | $14.3K | $3.9K | $2.4K | |||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $67.7M | $160.1M | $160.0M | $160.0M | $151.2M | $151.3M | $151.5M | |||||||||||||
| Deferred Underwriting Commissions In Connection With The Initial Public Offering | $5.6M | $5.6M | $5.6M | $5.6M | $5.6M | $5.6M | $5.6M | |||||||||||||
| Gain Loss On Investments | -$23.0K | -$45.0K | $293.0K | -$31.0K | $14.0K | -$314.0K | $1.7M | -$220.0K | ||||||||||||
| Assets Held In Trust Noncurrent | $67.8M | $160.2M | $160.0M | $160.0M | $160.0M | $160.0M | $160.0M | |||||||||||||
| Property Plant And Equipment Net | $1.6M | $1.4M | $1.4M | $1.3M | $1.2M | $1.3M | $1.4M | $1.4M | $1.5M | |||||||||||
| Prepaid Expense And Other Assets Current | $1.5M | $1.7M | $1.8M | $1.3M | $1.2M | $1.2M | $1.1M | $1.5M | $2.3M | |||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $147.0K | $54.0K | $155.0K | $132.0K | ||||||||||||||||
| Inventory Net | $365.0K | $185.0K | $135.0K | $234.0K | $70.0K | $115.0K | $137.0K | $178.0K | $232.0K | |||||||||||
| Deposits And Other Assets | $1.3M | $1.3M | $1.3M | $1.3M | $841.0K | $894.0K | $604.0K | $517.0K | $421.0K | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $45.0K | $16.0K | $37.0K | $98.0K | -$23.0K | -$8.0K | -$77.0K | -$96.0K | -$35.0K | |||||||||||
| Accounts Receivable Net Current | $52.0K | $83.0K | $89.0K | $115.0K | $80.0K | $67.0K | $86.0K | $171.0K | $76.0K | |||||||||||
| Operating Lease Right Of Use Asset | $1.7M | $1.8M | $2.0M | $1.7M | $1.3M | $1.5M | $1.7M | $1.9M | $2.0M | |||||||||||
| Operating Lease Liability Noncurrent | $1.1M | $1.3M | $1.5M | $1.4M | $1.1M | $1.2M | $1.1M | $1.3M | $1.5M | |||||||||||
| Operating Lease Liability Current | $696.0K | $642.0K | $590.0K | $395.0K | $350.0K | $465.0K | $747.0K | $729.0K | $711.0K | |||||||||||
| Marketable Securities Current | $53.8M | $15.2M | $31.5M | $41.3M | $41.5M | $51.7M | $89.4M | $101.3M | $108.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$49.0M | -$50.6M | -$46.1M | -$29.3M | -$272.4K |
| Net Cash Provided By Used In Financing Activities | $88.3M | $29.2M | $46.2M | $103.3M | |
| Net Cash Provided By Used In Investing Activities | -$26.9M | $13.1M | $10.7M | -$64.1M | |
| Increase Decrease In Accrued Liabilities | $1.4M | -$61.0K | |||
| Increase Decrease In Prepaid Expense | $77.3K | -$75.8K | |||
| Increase Decrease In Accounts Payable | $375.5K | -$12.4K | |||
| Share Based Compensation | $12.0M | $10.6M | $7.6M | $3.4M | |
| Proceeds From Stock Options Exercised | $91.0K | $240.0K | $231.0K | $121.0K | |
| Payments To Acquire Property Plant And Equipment | $489.0K | $289.0K | $78.0K | $591.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$880.0K | $1.1M | $781.0K | $439.0K | |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$150.0K | $120.0K | |||
| Increase Decrease In Inventories | $137.0K | $28.0K | -$131.0K | $208.0K | |
| Increase Decrease In Contract With Customer Liability | -$15.4M | -$2.0M | -$2.1M | -$2.9M | |
| Increase Decrease In Accounts Receivable | $3.0K | -$22.0K | $3.0K | -$25.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.9M | $3.0M | $145.0K | $3.4M | |
| Depreciation Depletion And Amortization | $327.0K | $308.0K | $287.0K | $222.0K | |
| Increase Decrease In Operating Lease Liability | -$550.0K | -$652.0K | -$693.0K | -$319.0K | |
| Payments To Acquire Marketable Securities | $76.3M | $72.6M | $142.0M | $63.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$16.6M | -$13.1M | -$14.4M | -$5.3M | -$76.4K | -$247.5K | |
| Net Cash Provided By Used In Financing Activities | -$296.0K | $18.0K | $56.8M | $24.8M | $162.3M | $193.7K | |
| Net Cash Provided By Used In Investing Activities | $13.0M | $5.9M | -$43.5M | -$47.0K | -$160.0M | ||
| Increase Decrease In Accrued Liabilities | $188.8K | $4.8K | -$5.0K | $15.2K | |||
| Increase Decrease In Prepaid Expense | $24.6K | $19.9K | $160.1K | ||||
| Increase Decrease In Accounts Payable | $102.2K | $20.8K | $1.4K | ||||
| Share Based Compensation | $3.0M | $2.6M | $1.5M | $70.0K | |||
| Proceeds From Stock Options Exercised | $91.0K | $18.0K | $10.0K | $25.0K | |||
| Payments To Acquire Property Plant And Equipment | $112.0K | $8.0K | $35.0K | $47.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$35.0K | $60.0K | $1.5M | -$72.0K | |||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$150.0K | $30.0K | |||||
| Increase Decrease In Inventories | -$38.0K | -$31.0K | -$44.0K | -$36.0K | |||
| Increase Decrease In Contract With Customer Liability | -$732.0K | -$497.0K | -$1.0M | -$716.0K | |||
| Increase Decrease In Accounts Receivable | -$3.0K | -$32.0K | -$20.0K | -$42.0K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$202.0K | -$1.3M | -$1.8M | $202.0K | |||
| Depreciation Depletion And Amortization | $83.0K | $74.0K | $71.0K | $48.0K | |||
| Increase Decrease In Operating Lease Liability | -$132.0K | -$63.0K | -$169.0K | $99.0K | |||
| Payments To Acquire Marketable Securities | $2.9M | $23.7M | $43.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 | |
| Weighted Average Number Of Shares Outstanding Basic | 47.7M | 36.8M | 33.2M | 15.0M | 20.5M | |
| Earnings Per Share Basic | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 | |
| Weighted Average Number Of Diluted Shares Outstanding | 47.7M | 36.8M | 33.2M | 15.0M | 20.5M | |
| Common Stock Shares Authorized | 340.0M | 340.0M | 340.0M | 340.0M | 100.0M | 100.0M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 57.0M | 38.2M | 35.8M | 20.2M | 4.5M | 4.5M |
| Common Stock Shares Issued | 57.0M | 38.2M | 35.8M | 20.2M | 4.5M | 4.5M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Temporary Equity Shares Outstanding | 200.0K | 0.00 | 6.8M | 16.0M | 16.0M | |
| Temporary Equity Shares Issued | 200.0K | 0.00 | 6.8M | 16.0M | 16.0M | |
| Temporary Equity Redemption Price Per Share | $10.01 | $10.00 | $10.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.40 | -$0.50 | -$0.49 | -$0.41 | -$0.45 | -$0.38 | -$0.38 | -$0.35 | -$0.40 | -$0.51 | -$0.77 | -$0.62 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 52.2M | 38.4M | 38.2M | 37.6M | 35.8M | 35.8M | 35.2M | 34.6M | 27.6M | 20.2M | 10.1M | 9.2M | 20.5M | 20.5M | 20.5M | |
| Earnings Per Share Basic | $-0.40 | $-0.50 | $-0.49 | $-0.41 | $-0.45 | $-0.38 | $-0.38 | $-0.35 | $-0.40 | $-0.51 | $-0.77 | $-0.62 | $0.00 | $0.00 | $-0.01 | |
| Weighted Average Number Of Diluted Shares Outstanding | 52.2M | 38.4M | 38.2M | 37.6M | 35.8M | 35.8M | 35.2M | 34.6M | 27.6M | 20.2M | 10.1M | 9.2M | 20.5M | 20.5M | ||
| Common Stock Shares Authorized | 340.0M | 340.0M | 340.0M | 340.0M | 340.0M | 340.0M | 340.0M | 340.0M | 340.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 56.5M | 38.6M | 38.3M | 37.9M | 35.8M | 35.8M | 35.7M | 35.7M | 31.7M | 4.5M | 4.5M | 4.5M | 4.5M | 5.3M | 5.3M | 5.3M |
| Common Stock Shares Issued | 56.5M | 38.6M | 38.3M | 37.9M | 35.8M | 35.8M | 35.7M | 35.7M | 31.7M | 4.5M | 4.5M | 4.5M | 4.5M | 5.3M | 5.3M | 5.3M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Temporary Equity Shares Outstanding | 6.8M | 16.0M | 16.0M | |||||||||||||
| Temporary Equity Shares Issued | 6.8M | 16.0M | 16.0M | |||||||||||||
| Temporary Equity Redemption Price Per Share | $10.01 | $10.01 | $10.00 | $10.00 | $10.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Administrative Fees Expense | $120.0K | $120.0K | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.0M | $10.6M | $7.6M | $3.4M | ||
| Stock Issued During Period Value Stock Options Exercised | $91.0K | $240.0K | $231.0K | $121.0K | ||
| Other Operating Income Expense Net | -$894.0K | $3.3M | $2.4M | -$951.0K | ||
| Costs And Expenses | $85.3M | $66.9M | $54.3M | $36.2M | ||
| Prepaid Expense Current | $123.9K | $46.7K | $122.5K | |||
| Additional Paid In Capital | $416.1M | $342.8M | $316.9M | $252.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Administrative Fees Expense | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | |||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.0M | $3.3M | $3.0M | $2.4M | $2.8M | $2.6M | $3.5M | $1.7M | $1.5M | $2.2M | $219.0K | $70.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $91.0K | $171.0K | $18.0K | $4.0K | $64.0K | $10.0K | $4.0K | $92.0K | $25.0K | ||||||||
| Other Operating Income Expense Net | -$515.0K | -$36.0K | $166.0K | $916.0K | $879.0K | $960.0K | $1.2M | $910.0K | $605.0K | -$215.0K | -$213.0K | -$601.0K | |||||
| Costs And Expenses | $21.2M | $20.2M | $19.8M | $17.3M | $17.6M | $15.0M | $14.9M | $13.9M | $12.7M | $11.2M | $8.0M | $6.0M | |||||
| Prepaid Expense Current | $137.3K | $36.4K | $71.3K | $81.2K | $105.7K | $142.4K | $160.1K | ||||||||||
| Additional Paid In Capital | $412.5M | $348.3M | $345.4M | $339.8M | $322.4M | $319.5M | $315.8M | $312.3M | $310.5M | $5.4M | $5.3M | $5.2M | $5.1M |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.